FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 03:50:40 2024-07-12 pm EDT | ||
| 1.49 EUR | +7.19% |
|
| Current month | +22.13% | ||
| 1 month | +40.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 1.49 | +7.19% |
| 24-07-11 | 1.39 | +4.51% |
| 24-07-10 | 1.33 | +7.26% |
| 24-07-09 | 1.24 | +5.08% |
| 24-07-08 | 1.18 | +0.85% |
Delayed Quote Deutsche Boerse AG
Last update July 12, 2024 at 03:50 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PF4AMG |
| ISIN | DE000PF4AMG9 |
| Date issued | 2020-02-27 |
| Strike | 325.1 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 2 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.4 € |
|---|---|
| Lowest since issue | 0.45 € |
| Spread | 0.01 € |
| Spread % | 0.67% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.8
USD
Average target price
317.4
USD
Spread / Average Target
-4.06%
- Stock Market
- Certificates
- Certificat
